Joseph C.
Papa founded Bionanosim (BNS) Ltd.
in 2023, where he worked as Chairman & Chief Executive Officer.
Mr. Papa also currently works at Emergent BioSolutions, Inc., as President, Chief Executive Officer & Director from 2024, SparingVision SAS, as Independent Chairman from 2023, Beyeonics Surgical Ltd., as Chairman from 2023, and various other companies.
Mr. Papa also formerly worked at Bausch & Lomb, Inc., as Chairman & Chief Executive Officer, Cardinal Health, Inc., as Chairman, CEO-Pharmaceutical & Technologies from 2004 to 2006, Perrigo Co., as Chairman, President & Chief Executive Officer from 2007 to 2016, and various other companies.
Mr. Papa received his undergraduate degree in 1978 from the University of Connecticut and Masters Business Admin degree from Kellogg School of Management.
View full profile
Linked companies |
---|
SparingVision SAS
BiotechnologyHealth Technology SparingVision SAS develops therapeutic approach for treatment of blinding inherited retinal diseases such as retinitis pigmentosa. The company was founded by Jose Alain Sahel, Thierry Leveillard and Florence Allouche Ghrenassia and is headquartered in Paris, France. |
Chairman
|
Beyeonics Surgical Ltd.
Medical/Nursing ServicesHealth Services Beyeonics Surgical Ltd. is a medical technology company based in Haifa, Israel. The Israeli company, along with its sister company Beyeonics Vision, develops and delivers digital surgical platforms to operating rooms across multiple therapeutic areas. Beyeonics Surgical focuses on orthopedic surgical platforms and has pipeline applications that include minimally invasive surgery utilizing VR and AR-based navigation and data processing. The company was founded by Avi Zeitouny and Ron Schneider, with Ron Schneider serving as CEO since incorporation. |
Chairman
|